Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Tanum

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|October 13, 2021
Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release NaltrexoneAnn Tarja Karlsson, John-Kåre Vederhus, Thomas Clausen, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 16, 2003
Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextractionSolveig Andersen, Trine Grønhaug Halvorsen, Stig Pedersen-Bjergaard, et al.
Journal of Affective Disorders|January 16, 2015
Clinical efficacy of formula-based bifrontal versus right unilateral electroconvulsive therapy (ECT) in the treatment of major depression among elderly patients: a pragmatic, randomized, assessor-blinded, controlled trialTor Magne Bjølseth, Knut Engedal, Jūratė Šaltytė Benth, et al.
Journal of Proteomics|April 16, 2018
Systematic analysis of the cerebrospinal fluid proteome of fibromyalgia patientsPayam Emami Khoonsari, Sravani Musunri, Stephanie Herman, et al.
Contemporary Clinical Trials|February 23, 2025
Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individualsKristin Klemmetsby Solli, Jūratė Šaltytė Benth, Linn Camilla Wergeland Digranes, et al.
Journal of Pain Research|February 26, 2025
Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory StudyFarid Juya, Ann Christin Sannes, Kristin Klemmetsby Solli, et al.
Brain Sciences|January 28, 2026
Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory StudyFarid Juya, Kristin Klemmetsby Solli, Ann-Christin Sannes, et al.
European Addiction Research|May 14, 2015
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009Gabrielle K Welle-Strand, Svetlana Skurtveit, Lars Tanum, et al.
Journal of Affective Disorders|July 6, 2015
Baseline cognitive function does not predict the treatment outcome of electroconvulsive therapy (ECT) in late-life depressionTor Magne Bjølseth, Knut Engedal, Jūratė Šaltytė Benth, et al.
Heliyon|July 14, 2023
Personal recovery among people with opioid use disorder during treatment with extended-release naltrexoneAnne Marciuch, Bente Birkeland, Jūratė Šaltytė Benth, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|October 13, 2021
Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release NaltrexoneAnn Tarja Karlsson, John-Kåre Vederhus, Thomas Clausen, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 16, 2003
Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextractionSolveig Andersen, Trine Grønhaug Halvorsen, Stig Pedersen-Bjergaard, et al.
Journal of Affective Disorders|January 16, 2015
Clinical efficacy of formula-based bifrontal versus right unilateral electroconvulsive therapy (ECT) in the treatment of major depression among elderly patients: a pragmatic, randomized, assessor-blinded, controlled trialTor Magne Bjølseth, Knut Engedal, Jūratė Šaltytė Benth, et al.
Journal of Proteomics|April 16, 2018
Systematic analysis of the cerebrospinal fluid proteome of fibromyalgia patientsPayam Emami Khoonsari, Sravani Musunri, Stephanie Herman, et al.
Contemporary Clinical Trials|February 23, 2025
Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individualsKristin Klemmetsby Solli, Jūratė Šaltytė Benth, Linn Camilla Wergeland Digranes, et al.
Journal of Pain Research|February 26, 2025
Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory StudyFarid Juya, Ann Christin Sannes, Kristin Klemmetsby Solli, et al.
Brain Sciences|January 28, 2026
Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory StudyFarid Juya, Kristin Klemmetsby Solli, Ann-Christin Sannes, et al.
European Addiction Research|May 14, 2015
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009Gabrielle K Welle-Strand, Svetlana Skurtveit, Lars Tanum, et al.
Journal of Affective Disorders|July 6, 2015
Baseline cognitive function does not predict the treatment outcome of electroconvulsive therapy (ECT) in late-life depressionTor Magne Bjølseth, Knut Engedal, Jūratė Šaltytė Benth, et al.
Heliyon|July 14, 2023
Personal recovery among people with opioid use disorder during treatment with extended-release naltrexoneAnne Marciuch, Bente Birkeland, Jūratė Šaltytė Benth, et al.
Pageof 6